Zacks Research Reduces Earnings Estimates for Henry Schein

Henry Schein, Inc. (NASDAQ:HSIC) – Investment analysts at Zacks Research reduced their Q1 2025 earnings per share (EPS) estimates for shares of Henry Schein in a note issued to investors on Tuesday, March 18th. Zacks Research analyst R. Department now expects that the company will earn $1.11 per share for the quarter, down from their prior forecast of $1.17. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. Zacks Research also issued estimates for Henry Schein’s Q2 2025 earnings at $1.21 EPS, Q3 2025 earnings at $1.26 EPS, Q4 2025 earnings at $1.26 EPS, FY2025 earnings at $4.84 EPS, Q1 2026 earnings at $1.32 EPS, Q2 2026 earnings at $1.36 EPS, Q3 2026 earnings at $1.25 EPS, Q4 2026 earnings at $1.39 EPS, FY2026 earnings at $5.31 EPS and FY2027 earnings at $5.74 EPS.

Other research analysts have also issued reports about the company. Mizuho began coverage on Henry Schein in a report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price target for the company. Barrington Research reaffirmed an “outperform” rating and set a $90.00 price objective on shares of Henry Schein in a research note on Wednesday, February 26th. UBS Group cut their price target on Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a report on Wednesday, February 26th. Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and boosted their price objective for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. Finally, Jefferies Financial Group raised their target price on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. Six research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $81.10.

Henry Schein Price Performance

NASDAQ HSIC opened at $69.39 on Thursday. Henry Schein has a fifty-two week low of $63.67 and a fifty-two week high of $82.49. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The stock’s 50-day moving average is $74.82 and its two-hundred day moving average is $72.60. The firm has a market cap of $8.62 billion, a P/E ratio of 28.56, a price-to-earnings-growth ratio of 2.13 and a beta of 0.90.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. During the same quarter last year, the firm posted $0.66 earnings per share. Henry Schein’s revenue was up 5.8% compared to the same quarter last year.

Hedge Funds Weigh In On Henry Schein

A number of hedge funds have recently bought and sold shares of the company. Wealth Enhancement Advisory Services LLC lifted its position in shares of Henry Schein by 34.0% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 52,891 shares of the company’s stock worth $3,660,000 after buying an additional 13,431 shares in the last quarter. Siemens Fonds Invest GmbH lifted its holdings in Henry Schein by 282.3% during the fourth quarter. Siemens Fonds Invest GmbH now owns 13,366 shares of the company’s stock worth $925,000 after acquiring an additional 9,870 shares during the period. Menard Financial Group LLC purchased a new position in Henry Schein in the fourth quarter worth $92,000. Universal Beteiligungs und Servicegesellschaft mbH bought a new position in Henry Schein in the 4th quarter valued at $5,743,000. Finally, Jefferies Financial Group Inc. increased its position in shares of Henry Schein by 98.8% during the 4th quarter. Jefferies Financial Group Inc. now owns 83,100 shares of the company’s stock valued at $5,751,000 after purchasing an additional 41,300 shares during the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the company’s stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the transaction, the chief executive officer now owns 62,688 shares in the company, valued at approximately $4,460,251.20. This represents a 6.05 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Philip A. Laskawy sold 2,604 shares of the business’s stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the sale, the director now directly owns 24,805 shares of the company’s stock, valued at approximately $1,762,147.20. The trade was a 9.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is owned by company insiders.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.